This webinar will explore cutting-edge innovations in the development of alternative methods to animal testing, focusing on how emerging technologies like bioinformatics and bioprinting are revolutionizing preclinical safety and efficacy assessments. Key topics include the integration of in silico tools for predictive toxicology, the advancements in 3D bioprinting to create realistic tissue models, and how these technologies are driving a shift towards more ethical, sustainable, and accurate testing methodologies in the cosmetic and pharmaceutical industries.

REGISTER

TIMES
Wednesday 2 October
8h West Coast USA • 9h Mexico City • 10h Chicago / Bogotá • 11h East Coast USA • 12h São Paulo • 16h London / West Africa • 17h Central Europe / Central & South Africa • 18h Tel Aviv / East Africa • 20:30h New Delhi • 23h Singapore / HK / China / Taipei • 0h Japan / Korea​​​​​​​
Thursday 3 October
1h Melbourne • 3h Wellington

BIOGRAPHY
Carolina Catarino is a Bioprocess Engineer and Biotechnologist, holding a Master’s in Clinical Analysis from the University of São Paulo and a PhD in Chemical Engineering from Rensselaer Polytechnic Institute (USA). Currently serving as Principal Scientist at Grupo Boticário, where she leads the Alternative Methods Laboratory and the Preclinical Evaluation Team. Carolina’s work is at the forefront of innovation in 3D bioprinting, specializing in the development of reconstructed skin models and the application of alternative methods for the safety assessment and preclinical efficacy testing of products. She is also deeply involved in outreach initiatives, advocating for the adoption of non-animal testing approaches within the cosmetic industry.